It took 20 years and $200 million in funding, but the FDA finally approved Swiss company Second Sight’s Argus II retinal prosthesis last week after the Opthalmic Device Panel unanimously voted in favor of approval last September. The system restores partial vision to sufferers of retinitis pigmentosa, an inherited disorder that progressively destroys the light-sensitive […]
The Vision Of The Future
